Amgen To Acquire Panitumumab Development Partner Abgenix
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies plan to submit a BLA for colorectal cancer agent panitumumab later this week.
You may also be interested in...
Affymax Considers Bankruptcy As Omontys Investigation Continues
Affymax cuts staff in order to conserve the little cash it has left in its coffers, which will be needed to pay down debts and continue looking into safety issues surrounding its sole commercial product – an investigation that may never be concluded because the company lacks resources.
Pfizer Hits Acquisition Trifecta: Snaps Up Serenex Hsp90 Candidate, Compound Library And Discovery Platform
Separately, Pfizer announces appointment of pharma exec Ringo to senior VP-strategy and business development.
Pfizer Hits Acquisition Trifecta: Snaps Up Serenex Hsp90 Candidate, Compound Library And Discovery Platform
Separately, Pfizer announces appointment of pharma exec Ringo to senior VP-strategy and business development.